Inventor · disambiguated record
Michael J. Massare
Also filed as: MASSARE MICHAEL · MASSARE MICHAEL J
24 granted patents·11 pending applications·250 citations·filing 2009–2024
96Inventor score
Top patents by PatentIndex Score
35 records- 0199US10953089B1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2020·Granted Mar 23, 2021·99 cites·20 claims
- 0298US11541112B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Jan 3, 2023·5 cites·20 claims
- 0397US10022437B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Jul 17, 2018·22 cites·16 claims
- 0496US12357684B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2022·Granted Jul 15, 2025·2 cites·14 claims
- 0596US11896664B2Corona virus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Feb 13, 2024·2 cites·34 claims
- 0696US11253586B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Feb 22, 2022·4 cites·26 claims
- 0796US11253585B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2019·Granted Feb 22, 2022·8 cites·27 claims
- 0895US10426829B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2016·Granted Oct 1, 2019·17 cites·14 claims
- 0995US8715692B2Modified RSV F proteins and methods of their usePUSHKO PETER·Filed 2009·Granted May 6, 2014·29 cites·19 claims
- 1092US11446374B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2019·Granted Sep 20, 2022·5 cites·12 claims
- 1192US11052146B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2018·Granted Jul 6, 2021·3 cites·20 claims
- 1292US9675685B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2014·Granted Jun 13, 2017·11 cites·15 claims
- 1391US9731000B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Aug 15, 2017·7 cites·18 claims
- 1491US9717786B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Aug 1, 2017·7 cites·17 claims
- 1591US8992939B2Highly efficient influenza matrix (M1) proteinsSMITH GALE·Filed 2011·Granted Mar 31, 2015·16 cites·20 claims
- 1689US9464276B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2015·Granted Oct 11, 2016·8 cites·16 claims
- 1788US12491241B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2023·Granted Dec 9, 2025·0 cites·11 claims
- 1888US11364294B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2017·Granted Jun 21, 2022·2 cites·24 claims
- 1985US12472246B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Nov 18, 2025·0 cites·12 claims
- 2082US12257297B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2022·Granted Mar 25, 2025·0 cites·30 claims
- 2180US12083228B2Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2018·Granted Sep 10, 2024·1 cites·18 claims
- 2277US2024423926A1Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2024·Application pending·0 cites
- 2375US9951317B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2016·Granted Apr 24, 2018·1 cites·20 claims
- 2474US10751410B2Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methodsNOVAVAX INC·Filed 2014·Granted Aug 25, 2020·1 cites·18 claims
- 2565US2013122032A1Recombinant nanoparticle rsv f vaccine for respiratory syncytial virusSMITH GALE·Filed 2012·Application pending·0 cites
- 2663US10544399B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2018·Granted Jan 28, 2020·0 cites·20 claims
- 2763US2017319682A1Recombinant nanoparticle rsv f vaccine for respiratory syncytial virusNOVAVAX INC·Filed 2017·Application pending·0 cites
- 2863US2022332765A1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Application pending·0 cites
- 2962US2025025549A1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Application pending·0 cites
- 3059US2015306207A1Recombinant nanoparticle rsv f vaccine for respiratory syncytial virusNovavax·Filed 2015·Application pending·0 cites
- 3157US2015335730A1Recombinant nanoparticle rsv f vaccine for respiratory syncytial virusNovavax·Filed 2015·Application pending·0 cites
- 3256US2022354944A1Coronavirus and influenza compositions and methods for using themNOVAVAX INC·Filed 2022·Application pending·0 cites
- 3356US2023070886A1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Application pending·0 cites
- 3449US2014271697A1Enhanced expression of picornavirus proteinsNOVAVAX INC·Filed 2014·Application pending·0 cites
- 3541US2017354729A1Vaccine compositions containing modified zika virus antigensNOVAVAX INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →